Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


15.05.2017

1 Anticancer Res
3 BJU Int
1 BMC Cancer
1 BMC Urol
1 Br J Radiol
2 Cancer Res
2 Clin Cancer Res
1 J Clin Oncol
2 J Nucl Med
1 J Urol
1 Nat Rev Urol
1 Oncol Rep
1 PLoS One
1 Prog Urol
1 Prostate
1 Urol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. OU YC, Hung SC, Hwang LH, Yang CK, et al
    Salvage Robotic-assisted Laparoscopic Radical Prostatectomy: Experience with 14 Cases.
    Anticancer Res. 2017;37:2045-2050.
    PubMed     Text format     Abstract available


    BJU Int

  2. CARLSSON S, Drevin L, Loeb S, Widmark A, et al
    Population-based study of long-term functional outcomes after prostate cancer treatment.
    BJU Int. 2015 May 8. doi: 10.1111/bju.13179.
    PubMed     Text format     Abstract available

  3. TOSOIAN JT, Chappidi MR, Bishoff JT, Freedland SJ, et al
    Prognostic Utility of Biopsy-Derived Cell Cycle Progression Score in Patients with NCCN Low-Risk Prostate Cancer Undergoing Radical Prostatectomy: Implications for Treatment Guidance.
    BJU Int. 2017 May 8. doi: 10.1111/bju.13911.
    PubMed     Text format     Abstract available

  4. CHIU PKF, Alberts AR, Venderbos LDF, Bangma CH, et al
    Additional benefit of using a risk based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    BJU Int. 2017 May 12. doi: 10.1111/bju.13913.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. KAWAKAMI K, Fujita Y, Matsuda Y, Arai T, et al
    Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
    BMC Cancer. 2017;17:316.
    PubMed     Text format     Abstract available


    BMC Urol

  6. MADER EM, Li HH, Lyons KD, Morley CP, et al
    Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
    BMC Urol. 2017;17:35.
    PubMed     Text format     Abstract available


    Br J Radiol

  7. ROBINSON JL, Tzou KS, Parker AS, Heckman MG, et al
    GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer.
    Br J Radiol. 2017 May 9:20170174. doi: 10.1259/bjr.20170174.
    PubMed     Text format     Abstract available


    Cancer Res

  8. PALTOGLOU S, Das R, Townley SL, Hickey T, et al
    Novel androgen receptor co-regulator GRHL2 exerts both oncogenic and anti-metastatic functions in prostate cancer.
    Cancer Res. 2017 May 4. pii: canres.1616.2016.
    PubMed     Text format     Abstract available

  9. MALEK R, Gajula RP, Williams RD, Nghiem B, et al
    TWIST1-WDR5-Hottip regulates Hoxa9 chromatin to facilitate prostate cancer metastasis.
    Cancer Res. 2017 May 8. pii: canres.2797.2016.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  10. KOHLI M, Ho Y, Hillman DW, Van Etten JL, et al
    Androgen receptor variant AR-V9 is co-expressed with AR-V7 in prostate cancer metastases and predicts abiraterone resistance.
    Clin Cancer Res. 2017 May 4. pii: clincanres.0017.2017.
    PubMed     Text format     Abstract available

  11. BAN K, Feng S, Shao L, Ittmann M, et al
    RET signaling in prostate cancer.
    Clin Cancer Res. 2017 May 10. pii: clincanres.0528.2017.
    PubMed     Text format     Abstract available


    J Clin Oncol

  12. HOFFMAN RM, Lo M, Clark JA, Albertsen PC, et al
    Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
    J Clin Oncol. 2017 May 11:JCO2016706317. doi: 10.1200/JCO.2016.70.6317.
    PubMed     Text format     Abstract available


    J Nucl Med

  13. CYSOUW MC, Kramer GM, Hoekstra OS, Frings V, et al
    Accuracy and precision of partial volume correction in oncological PET/CT studies.
    J Nucl Med. 2016 May 26. pii: jnumed.116.173831.
    PubMed     Text format     Abstract available

  14. KESCH C, Vinsensia M, Radtke JP, Schlemmer HP, et al
    Intra-individual comparison of 18F-PSMA-1007-PET/CT, multi-parametric MRI and radical prostatectomy specimen in patients with primary prostate cancer - a retrospective, proof of concept study.
    J Nucl Med. 2017 May 4. pii: jnumed.116.189233. doi: 10.2967/jnumed.116.189233.
    PubMed     Text format     Abstract available


    J Urol

  15. HENRY MA, Howard DH, Davies BJ, Filson CP, et al
    Variation in Use of Prostate Biopsy Following Changes in Prostate Cancer Screening Guidelines.
    J Urol. 2017 May 6. pii: S0022-5347(17)64683-4. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  16. FENNER A
    Prostate cancer: PCA3 as a Grade Reclassification Predictor.
    Nat Rev Urol. 2017 May 9. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    Oncol Rep

  17. LIU L, Lou N, Li X, Xu G, et al
    Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells.
    Oncol Rep. 2017 May 4. doi: 10.3892/or.2017.5623.
    PubMed     Text format     Abstract available


    PLoS One

  18. OKEYO-OWUOR T, Benesh E, Bibbey S, Reid M, et al
    Exposure to maternal obesogenic diet worsens some but not all pre-cancer phenotypes in a murine genetic model of prostate cancer.
    PLoS One. 2017;12:e0175764.
    PubMed     Text format     Abstract available


    Prog Urol

  19. GIRIER D, Chevrot A, Costa P, Thuret R, et al
    [Sexual consequences after treatment of prostate cancer: Inquiry among members of the Association Nationale des Malades du Cancer de la Prostate].
    Prog Urol. 2017 May 5. pii: S1166-7087(17)30075.
    PubMed     Text format     Abstract available


    Prostate

  20. ARMSTRONG CM, Liu C, Lou W, Lombard AP, et al
    MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.
    Prostate. 2017;77:1020-1028.
    PubMed     Text format     Abstract available


    Urol Int

  21. PORCARO AB, De Luyk N, Corsi P, Sebben M, et al
    Clinical Factors Predicting Bilateral Lymph Node Invasion in High-Risk Prostate Cancer.
    Urol Int. 2017 May 10. doi: 10.1159/000476039.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: